CN115590118A - Melanoidin composition and preparation method thereof - Google Patents
Melanoidin composition and preparation method thereof Download PDFInfo
- Publication number
- CN115590118A CN115590118A CN202210176411.0A CN202210176411A CN115590118A CN 115590118 A CN115590118 A CN 115590118A CN 202210176411 A CN202210176411 A CN 202210176411A CN 115590118 A CN115590118 A CN 115590118A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- melanoidin
- amino acid
- chicken liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 45
- 150000004676 glycans Chemical class 0.000 claims abstract description 42
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 42
- 239000005017 polysaccharide Substances 0.000 claims abstract description 42
- 241000287828 Gallus gallus Species 0.000 claims abstract description 38
- 210000004185 liver Anatomy 0.000 claims abstract description 37
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 150000001413 amino acids Chemical class 0.000 claims abstract description 31
- 229920001491 Lentinan Polymers 0.000 claims abstract description 26
- 229940115286 lentinan Drugs 0.000 claims abstract description 26
- 235000000346 sugar Nutrition 0.000 claims abstract description 24
- 239000005543 nano-size silicon particle Substances 0.000 claims abstract description 17
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 229940024606 amino acid Drugs 0.000 claims description 30
- 235000001014 amino acid Nutrition 0.000 claims description 30
- 230000002255 enzymatic effect Effects 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 18
- 241000199919 Phaeophyceae Species 0.000 claims description 16
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 15
- 235000004400 serine Nutrition 0.000 claims description 15
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 14
- 229920002472 Starch Polymers 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 239000004302 potassium sorbate Substances 0.000 claims description 14
- 229940069338 potassium sorbate Drugs 0.000 claims description 14
- 235000010241 potassium sorbate Nutrition 0.000 claims description 14
- 239000008107 starch Substances 0.000 claims description 14
- 235000019698 starch Nutrition 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 239000004475 Arginine Substances 0.000 claims description 9
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 9
- 239000004471 Glycine Substances 0.000 claims description 9
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 9
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 9
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 9
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 9
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 9
- 239000004472 Lysine Substances 0.000 claims description 9
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 9
- 239000004473 Threonine Substances 0.000 claims description 9
- 235000004279 alanine Nutrition 0.000 claims description 9
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 9
- 235000009697 arginine Nutrition 0.000 claims description 9
- 235000003704 aspartic acid Nutrition 0.000 claims description 9
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 9
- 235000013922 glutamic acid Nutrition 0.000 claims description 9
- 239000004220 glutamic acid Substances 0.000 claims description 9
- 235000014304 histidine Nutrition 0.000 claims description 9
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 9
- 235000014705 isoleucine Nutrition 0.000 claims description 9
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 9
- 229960000310 isoleucine Drugs 0.000 claims description 9
- 235000005772 leucine Nutrition 0.000 claims description 9
- 235000018977 lysine Nutrition 0.000 claims description 9
- 229930182817 methionine Natural products 0.000 claims description 9
- 235000008729 phenylalanine Nutrition 0.000 claims description 9
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 9
- 235000008521 threonine Nutrition 0.000 claims description 9
- 235000002374 tyrosine Nutrition 0.000 claims description 9
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 9
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 8
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 8
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 8
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 8
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 8
- 235000009582 asparagine Nutrition 0.000 claims description 8
- 229960001230 asparagine Drugs 0.000 claims description 8
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 8
- 235000004554 glutamine Nutrition 0.000 claims description 8
- 235000013930 proline Nutrition 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 7
- 229930091371 Fructose Natural products 0.000 claims description 7
- 239000005715 Fructose Substances 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 7
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 7
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 7
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- 239000004474 valine Substances 0.000 claims description 7
- 241001474374 Blennius Species 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 2
- 108010087806 Carnosine Proteins 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 2
- 241001260874 Sargassum horneri Species 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 2
- 229940044199 carnosine Drugs 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 241000282326 Felis catus Species 0.000 abstract description 21
- 241000282472 Canis lupus familiaris Species 0.000 abstract description 13
- 239000000796 flavoring agent Substances 0.000 abstract description 12
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 235000019634 flavors Nutrition 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002245 particle Substances 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 4
- 230000036528 appetite Effects 0.000 abstract description 3
- 235000019789 appetite Nutrition 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 230000003832 immune regulation Effects 0.000 abstract description 2
- 108010005094 Advanced Glycation End Products Proteins 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 12
- 235000019629 palatability Nutrition 0.000 description 10
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 235000019750 Crude protein Nutrition 0.000 description 5
- 229920000855 Fucoidan Polymers 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 3
- 239000011265 semifinished product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000282465 Canis Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- -1 compound amino acid Chemical class 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 230000035553 feeding performance Effects 0.000 description 1
- 108010007119 flavourzyme Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to A23K, in particular to a melanoidin composition and a preparation method thereof. The composition comprises the following raw materials in parts by weight: 60-80 parts of enzymolysis chicken liver powder, 20-30 parts of lentinan, 5-15 parts of amino acid, 10-40 parts of reducing sugar and 0.1-2 parts of nano silicon dioxide. According to the invention, chicken liver powder, amino acid and polysaccharide are selected to carry out Maillard reaction to obtain flavor components, the appetite of pets such as cats and dogs is promoted, meanwhile, nano silicon dioxide is added, lentinan is added to exert an immune regulation function, certain nano silicon dioxide is promoted to be attached to the surface of the Maillard reaction product, the uniform particle size of the dried reaction product is improved, the adhesion of various components is promoted, the adhesion problem in a high-humidity or high-temperature environment is reduced by adding algal polysaccharide with multiple functions such as virus resistance, the effect of the feed for pets is not influenced, and the feed can be used for long-term feeding of a large number of cats and dogs.
Description
Technical Field
The invention relates to A23K, in particular to a melanoidin composition and a preparation method thereof.
Background
At present, pet food is gradually increased, the requirement on the pet food is also gradually increased, and the flavoring agent is used as a common pet food additive and mainly comprises liquid and powder for improving the palatability of pets.
CN105961881B discloses a powdery pet food flavoring agent and a preparation method thereof, wherein the flavoring agent comprises meat substances, purified water, animal protease, flavourzyme, lipase, edible chicken fat, saccharides, compound amino acid, egg powder, maltodextrin, a preservative, salt and an adhesive. Has good palatability.
However, the existing powdery flavoring agent also has the problems of poor fluidity and easy caking in long-term storage, which influences the use of the powdery flavoring agent.
Disclosure of Invention
In order to solve the above problems, the first aspect of the present invention provides a melanoidin composition, which is prepared from the following raw materials in parts by weight: 60-80 parts of enzymolysis chicken liver powder, 20-30 parts of lentinan, 5-15 parts of amino acid, 10-40 parts of reducing sugar, 0.1-0.5 part of potassium sorbate and 0.1-2 parts of nano silicon dioxide.
Lentinan, as the main active ingredient of lentinus edodes, is branched beta- (1-3) -D-glucan in a comb-like structure, and the aqueous solution of the lentinan is transparent and viscous and has the functions of resisting virus, regulating immune function, resisting tumor, stimulating the formation of interferon and the like. The amino acid and various reducing sugars are adopted to generate Maillard reaction, meanwhile, the enzymolysis chicken liver powder is added to further increase the appetite of pets, and the inventor finds that the addition of lentinan is also favorable for playing the roles of resisting virus and regulating the immune function, is favorable for improving the intestines and stomach, and further improves the palatability.
As a preferable technical scheme, the preparation raw materials of the composition comprise 1-4 parts by weight of algal polysaccharide; the algal polysaccharide is fucoidin and brown algae starch, and the weight ratio is 1:1 to 2; the brown algae starch is extracted from kelp or sargassum horneri, preferably the kelp; the fucoidin is extracted from brown algae.
The brown algae starch is mainly a polymer of beta-D-glucose connected by 1 and 3 type glycosidic bonds and has a sulfate structure (n = about 20); fucoidan is a water-soluble polysaccharide substance composed of fucose containing sulfate group, wherein fucoidan and brown algae starch have immunoregulatory, antiviral and antioxidant effects. And the seaweed polysaccharide, particularly the fucoidin and the brown algae starch containing sulfate radical are dried by water treatment, so that the effects of resisting virus and oxidation, improving the immunity and promoting the health of pets can be achieved, a certain bonding effect can be achieved, the adhesion of substances such as Maillard reactants to pet feeds is facilitated, and the increase of the food intake for a long time is promoted.
As a preferable technical scheme, the content of crude protein in the enzymatic chicken liver powder is more than or equal to 60%, the content of fat is more than or equal to 18%, and the content of water is 7%, and the protein amino acid composition in the enzymatic chicken liver powder comprises arginine, alanine, aspartic acid, threonine, tyrosine, histidine, glutamic acid, lysine, phenylalanine, leucine, isoleucine, serine, glycine, methionine and valine. The contents are mass contents. The amino acid composition was tested according to GB T18246.
As a preferable technical scheme of the invention, the protein composition in the enzymatic chicken liver powder comprises 3.51% of arginine, 3.27% of alanine, 5.18% of aspartic acid, 2.55% of threonine, 2.14% of tyrosine, 1.7% of histidine, 7.32% of glutamic acid, 3.85% of lysine, 3.27% of phenylalanine, 4.75% of leucine, 2.43% of isoleucine, 2.33% of serine, 2.71% of glycine, 1.32% of methionine and 3.17% of valine.
In a preferred embodiment of the present invention, the amino acid is selected from the group consisting of arginine, alanine, leucine, aspartic acid, cysteine, tryptophan, threonine, tyrosine, carnosine, histidine, glutamine, asparagine, glutamic acid, lysine, phenylalanine, isoleucine, serine, glycine, methionine, and proline.
As a preferable technical scheme of the invention, the amino acid comprises glutamine, asparagine, serine and proline, and the weight ratio is 1-2: 3 to 4:1 to 2:0.5 to 1.
In a preferred embodiment of the present invention, the reducing sugar is selected from one or a combination of more of glucose, fructose, galactose, lactose, and maltose, preferably glucose, fructose, and maltose, and the weight ratio is 4-5: 1 to 2:1 to 2.
The inventor finds that by selecting the protein composition of the enzymatic hydrolysis chicken liver powder and selecting proper amino acid and reducing sugar for Maillard, the flavor of the flavoring agent can be adjusted, the feeding performance and the feed intake of different cats and dogs are improved, and the widely applicable pet food additive is obtained.
As a preferable technical scheme of the invention, the specific surface area of the nano silicon dioxide is 165-215m 2 A particle size of 10-20nm (165-215M specific surface area), such as M600 from Guangzhou Macrowu materials science and technology Limited 2 (iii)/g, particle diameter of 10-20 nm). In addition, the inventor finds that the reaction rate of the invention is promoted by using the porous structure of the nano-silicon dioxide added in the Maillard reaction process, and the particle size of the nano-silicon dioxide, chicken liver powder and lentinan is improved to generate a certain coating effect, so that the moisture absorption and the adhesiveness are reduced in the subsequent use and storage processes, and the free flow of the composition is promoted.
In a second aspect, the invention provides a method for preparing the melanoidin composition, which comprises the following steps:
(1) Reacting enzymolysis chicken liver powder, lentinan, amino acid, reducing sugar and nano silicon dioxide at 105-110 ℃ for 100-200 min to obtain a premix;
(2) Adding algal polysaccharide into water, mixing for 40-60 min at 80-90 ℃, and air-drying to obtain an algal polysaccharide mixture;
(3) And cooling the premix to 80-90 ℃, and adding the algal polysaccharide mixture and potassium sorbate to obtain the composition.
As a preferable technical scheme, in the step (1), lentinan, reducing sugar and nano-silica are ground, water is added, and enzymolysis chicken liver powder and amino acid are added to react at 105-110 ℃ for 100-200 min. The inventors have also found that by grinding nanosilicon dioxide, polysaccharide and reducing sugar and then adding water and amino acid to the ground nanosilicon dioxide to carry out the maillard reaction, the reaction can be further accelerated and the dimensional unevenness after air drying can be reduced.
As a preferred technical scheme of the invention, in the step (3), the premix is cooled to 80-90 ℃, potassium sorbate is added, after mixing for 10-15 min, the temperature is cooled to 60-70 ℃, the algal polysaccharide mixture is added, and the mixture is mixed and dried to obtain the composition; the seaweed polysaccharide mixture is crushed before being added. And the seaweed polysaccharide is treated by water before being added, so that the seaweed polysaccharide is favorably quickly dispersed into the premix after being cooled to 60-70 ℃, and has the functions of lentinan and the like, and the obtained composition has good long-term use by utilizing the combination of silicon dioxide pre-adsorption and polysaccharide double-layer coating.
Compared with the prior art, the invention has the following beneficial effects:
according to the invention, chicken liver powder, amino acid and polysaccharide are selected to carry out Maillard reaction to obtain flavor components, the appetite of pets such as cats and dogs is promoted, nano silicon dioxide is added and lentinan is added in the Maillard reaction process to play an immune regulation function, and simultaneously, certain nano silicon dioxide is promoted to be attached to the surface of a Maillard reactant, the uniform particle size of the dried reactant is improved, the adhesion of various components is promoted by adding algal polysaccharide with multiple functions such as antivirus, the adhesion problem in a high-humidity or high-temperature environment is reduced, the effect of the feed for pets is not influenced, and the feed can be used for feeding a large number of cats and dogs for a long time.
Drawings
Figure 1 is a picture of a cat palatability trial.
Fig. 2 is a picture of a canine palatability trial feed.
Fig. 3 is a picture of the composition provided in example 3 after 30 days at 30 ℃ on the left, and fig. 3 is a picture of the composition provided in example 2 after 30 days at 30 ℃.
Detailed Description
Examples
Example 1
The embodiment provides a composition, which is prepared from the following raw materials in parts by weight: 60 parts of enzymolysis chicken liver powder, 20 parts of lentinan, 5 parts of amino acid, 10 parts of reducing sugar, 0.1 part of potassium sorbate, 1 part of nano silicon dioxide and 2 parts of algal polysaccharide; the algal polysaccharide is fucoidin and brown algae starch, and the weight ratio is 1:1, the content of crude protein in the enzymatic chicken liver powder is more than or equal to 60%, the content of fat is more than or equal to 18%, and the content of water is 7%, the protein composition in the enzymatic chicken liver powder comprises 3.51% of arginine, 3.27% of alanine, 5.18% of aspartic acid, 2.55% of threonine, 2.14% of tyrosine, 1.7% of histidine, 7.32% of glutamic acid, 3.85% of lysine, 3.27% of phenylalanine, 4.75% of leucine, 2.43% of isoleucine, 2.33% of serine, 2.71% of glycine, 1.32% of methionine and 3.17% of valine, the amino acids comprise glutamine, asparagine, serine and proline, and the weight ratio is 1:3:1:0.5, the reducing sugar is glucose, fructose and maltose, and the weight ratio is 4:1:1.
the enzymatic chicken liver powder is purchased from Nanjing Qiarun biotechnology Limited.
The lentinan is purchased from Shandong green leaf pharmaceutical Co.
The fucoidan is purchased from Shanxi New Tian Domain Biotechnology GmbH.
The brown algae starch is purchased from Shaanxi New Tian Domain Biotechnology Co.
The nanosilica was purchased from M600, guangzhou martial materials technologies, inc.
This example also provides a method of preparing a composition as described above, comprising:
(1) Grinding lentinan, reducing sugar and nano-silica, adding water, adding enzymolysis chicken liver powder and amino acid, and reacting at 105 deg.C for 100min to obtain a premix;
(2) Adding algal polysaccharide into water, mixing for 40min at 80 ℃, and air-drying to obtain algal polysaccharide mixture;
(3) Cooling the premix to 80 ℃, adding potassium sorbate, mixing for 10min, cooling to 60 ℃, adding the algal polysaccharide mixture, mixing and drying to obtain the composition.
Example 2
The embodiment provides a composition, which is prepared from the following raw materials in parts by weight: 80 parts of enzymolysis chicken liver powder, 30 parts of lentinan, 15 parts of amino acid, 40 parts of reducing sugar, 0.5 part of potassium sorbate, 2 parts of nano silicon dioxide and 4 parts of algal polysaccharide; the algal polysaccharide is fucoidin and brown algae starch, and the weight ratio is 1:1, the content of crude protein in the enzymatic chicken liver powder is more than or equal to 60%, the content of fat is more than or equal to 18%, and the content of water is 7%, the protein composition in the enzymatic chicken liver powder comprises 3.51% of arginine, 3.27% of alanine, 5.18% of aspartic acid, 2.55% of threonine, 2.14% of tyrosine, 1.7% of histidine, 7.32% of glutamic acid, 3.85% of lysine, 3.27% of phenylalanine, 4.75% of leucine, 2.43% of isoleucine, 2.33% of serine, 2.71% of glycine, 1.32% of methionine and 3.17% of valine, the amino acids comprise glutamine, asparagine, serine and proline in a weight ratio of 2:4:2:1, the reducing sugar is glucose, fructose and maltose, and the weight ratio is 5:2:2.
the enzymatic chicken liver powder is purchased from Nanjing Qiarun biotechnology Limited.
The lentinan is available from Shandong Green leaf pharmaceutical Co., ltd.
The fucoidan is purchased from Shanxi New Tian Domain Biotechnology GmbH.
The brown algae starch is purchased from Shaanxi New Tian Domain Biotechnology Co.
The nanosilica was purchased from M600, guangzhou martial materials technologies, inc.
This example also provides a method of preparing a composition as described above, comprising:
(1) Grinding lentinan, reducing sugar and nano-silica, adding water, adding enzymatic chicken liver powder and amino acid, and reacting at 110 deg.C for 200min to obtain a premix;
(2) Adding algal polysaccharide into water, mixing for 60min at 90 ℃, and air-drying to obtain an algal polysaccharide mixture;
(3) Cooling the premix to 90 ℃, adding potassium sorbate, mixing for 15min, cooling to 70 ℃, adding the algal polysaccharide mixture, mixing and drying to obtain the composition.
Example 3
The embodiment provides a composition, and the composition is prepared from the following raw materials in parts by weight: 80 parts of enzymolysis chicken liver powder, 5 parts of lentinan, 15 parts of amino acid, 40 parts of reducing sugar, 0.5 part of potassium sorbate and 4 parts of algal polysaccharide; the algal polysaccharide is fucoidin and brown algae starch, and the weight ratio is 1:1, the content of crude protein in the enzymatic chicken liver powder is more than or equal to 60%, the content of fat is more than or equal to 18%, and the content of water is 7%, the protein composition in the enzymatic chicken liver powder comprises 3.51% of arginine, 3.27% of alanine, 5.18% of aspartic acid, 2.55% of threonine, 2.14% of tyrosine, 1.7% of histidine, 7.32% of glutamic acid, 3.85% of lysine, 3.27% of phenylalanine, 4.75% of leucine, 2.43% of isoleucine, 2.33% of serine, 2.71% of glycine, 1.32% of methionine and 3.17% of valine, the amino acids comprise glutamine, asparagine, serine and proline, and the weight ratio is 2:4:2:1, the reducing sugar is glucose, fructose and maltose, and the weight ratio is 5:2:2.
the enzymatic chicken liver powder is purchased from Nanjing Qiarun biotechnology Limited.
The lentinan is available from Shandong Green leaf pharmaceutical Co., ltd.
The fucoidan is purchased from Shanxi New Tian Domain Biotechnology GmbH.
The brown algae starch is purchased from Shaanxi New Tian Domain Biotechnology Co.
This example also provides a method of preparing a composition as described above, comprising:
(1) Grinding lentinan, reducing sugar and nano-silica, adding water, adding enzymolysis chicken liver powder and amino acid, and reacting at 110 deg.C for 200min to obtain a premix;
(2) Adding algal polysaccharide into water, mixing for 60min at 90 ℃, and air-drying to obtain algal polysaccharide mixture;
(3) Cooling the premix to 90 ℃, adding potassium sorbate, mixing for 15min, cooling to 70 ℃, adding the algal polysaccharide mixture, mixing and drying to obtain the composition.
Example 4
The embodiment provides a composition, and the composition is prepared from the following raw materials in parts by weight: 80 parts of enzymolysis chicken liver powder, 30 parts of lentinan, 15 parts of amino acid, 40 parts of reducing sugar, 0.5 part of potassium sorbate, 2 parts of nano silicon dioxide and 4 parts of algal polysaccharide; the algal polysaccharide is fucoidin and brown algae starch, and the weight ratio is 1: 1-2, the content of crude protein in the enzymatic chicken liver powder is more than or equal to 60%, the content of fat is more than or equal to 18%, and the content of water is 7%, the protein composition in the enzymatic chicken liver powder comprises 3.51% of arginine, 3.27% of alanine, 5.18% of aspartic acid, 2.55% of threonine, 2.14% of tyrosine, 1.7% of histidine, 7.32% of glutamic acid, 3.85% of lysine, 3.27% of phenylalanine, 4.75% of leucine, 2.43% of isoleucine, 2.33% of serine, 2.71% of glycine, 1.32% of methionine and 3.17% of valine, the amino acid comprises glutamine, asparagine, serine and proline, and the weight ratio is 2:4:2:1, the reducing sugar is glucose, fructose and maltose, and the weight ratio is 5:2:2.
the enzymatic chicken liver powder is purchased from Nanjing Qiarun biotechnology Limited.
The lentinan is available from Shandong Green leaf pharmaceutical Co., ltd.
The nanosilica was purchased from M600, guangzhou martial materials science and technology ltd.
This example also provides a method of preparing a composition as described above, comprising:
(1) Grinding lentinan, reducing sugar and nano-silica, adding water, adding enzymatic chicken liver powder and amino acid, and reacting at 110 deg.C for 200min to obtain a premix;
(2) Cooling the premix to 90 ℃, adding potassium sorbate, mixing for 15min, cooling to 70 ℃, adding algal polysaccharide, mixing and drying to obtain the composition.
Evaluation of Properties
1. Cat palatability: the composition provided in example 1 was added to a cat food intermediate (supplied by Shanghai Birgiji Pet products, inc.) as group B and a commercially available cat food intermediate with a cat food flavor added as group A to conduct a cat palatability test, as shown in FIG. 1, wherein the amount of composition or flavor added was 2% of the cat food intermediate, and the results are shown in Table 1.
The feeding method and requirements are as follows:
(1) Feeding time: 14 parts per day: 00 to 8 in the morning of the next day: 00 is folded, and the feed is weighed in the morning the next day after the feed is fed on the same day;
(2) Feeding dosage: A. 120g of each group B, the positions of the groups A and B are exchanged when the group B feeds the food at the next meal, and the dry food fed by each meal cannot be reused;
(3) Feeding cats to select adult cats, and testing cat varieties: 4 cats such as the short-necked cat, the Siamese cat, the gold gradual layer cat, the three-flower cat and the blue cat respectively have good health condition and no symptoms such as vomiting and diarrhea.
TABLE 1
2. Canine palatability: the composition provided in example 2 was added to a certain dog food semi-finished product (provided by shanghai nemacy pet products, inc.) as group a and a commercially available dog food semi-finished product with a flavor added thereto as group B to perform a dog palatability test, as shown in fig. 2, wherein the amount of the composition or the flavor added was 2% of the dog food semi-finished product, and the results are shown in table 2.
The feeding method and requirements are as follows:
(1) Feeding time: one morning and one evening, which are respectively 8 in the afternoon: 00 and 16 pm: 00, each meal is 30min, or the food intake of any one of A and B is finished;
(2) Feeding dosage: A. the group B respectively has 150g, when the group A and the group B exchange positions for feeding at next meal, the dry food fed by each meal cannot be reused;
(3) The feed dog selects 25 dogs, and the dogs have good health condition and no symptoms of vomiting, diarrhea and the like.
TABLE 2
3. Fluidity: the compositions provided in examples were filled in vials, and after being respectively placed in a sealed vertical state at 30 ℃ for 30 days, the vials were leveled to observe whether or not the powder of the compositions flowed, and the results are shown in table 3.
TABLE 3
| Examples | Fluidity of the resin |
| 1 | The powder flows to the horizontal position rapidly, the bottom is bottomless |
| 2 | The powder flows to the horizontal position rapidly, the bottom is bottomless |
| 3 | The powder does not flow and is fixed at the bottom of the small bottle |
| 4 | The powder flows at the bottom, and the bottom powder is fixed at the bottom of the bottle |
According to test results, the melanoidin composition provided by the invention has good palatability and fluidity and can be used for feeding various pets such as cats, dogs and the like.
Claims (10)
1. The melanoidin composition is characterized by comprising the following raw materials in parts by weight: 60-80 parts of enzymolysis chicken liver powder, 20-30 parts of lentinan, 5-15 parts of amino acid, 10-40 parts of reducing sugar, 0.1-0.5 part of potassium sorbate and 0.1-2 parts of nano silicon dioxide.
2. The melanoidin composition as claimed in claim 1, wherein the raw materials for preparing the composition comprise, by weight, 1-4 parts of algal polysaccharides; the algal polysaccharides are fucoidin and brown algae starch; the brown algae starch is extracted from kelp or sargassum horneri, and the fucoidin is extracted from brown algae.
3. The melanoidin composition of claim 1, wherein the protein content of the enzymatic chicken liver powder is not less than 60%, the fat content is not less than 18%, and the moisture content is 7%, and the amino acid composition of the protein of the enzymatic chicken liver powder comprises arginine, alanine, aspartic acid, threonine, tyrosine, histidine, glutamic acid, lysine, phenylalanine, leucine, isoleucine, serine, glycine, methionine, and valine.
4. The melanoidin composition according to claim 3, wherein the amino acid is selected from the group consisting of arginine, alanine, leucine, aspartic acid, cysteine, tryptophan, threonine, tyrosine, carnosine, histidine, glutamine, asparagine, glutamic acid, lysine, phenylalanine, isoleucine, serine, glycine, methionine, proline in combination with one or more thereof.
5. The melanoidin composition according to claim 4, wherein the amino acids include glutamine, asparagine, serine, proline.
6. The melanoidin composition according to any one of claims 1 to 5, wherein the specific surface area of the nanosilica is 165-215m 2 The grain diameter is 10-20nm.
7. The melanoidin composition according to any one of claims 1 to 5, wherein the reducing sugar is selected from one or more of glucose, fructose, galactose, lactose and maltose.
8. A method of preparing a melanoidin composition as claimed in any one of claims 1 to 7, wherein the method of preparing the melanoidin composition comprises:
(1) Reacting enzymolysis chicken liver powder, lentinan, amino acid, reducing sugar and nano silicon dioxide at 105-110 ℃ for 100-200 min to obtain a premix;
(2) Adding algal polysaccharide into water, mixing for 40-60 min at 80-90 ℃, and air-drying to obtain an algal polysaccharide mixture;
(3) And cooling the premix to 80-90 ℃, and adding the seaweed polysaccharide mixture and potassium sorbate to obtain the composition.
9. The method for preparing a melanoidin composition according to claim 8, wherein in the step (1), lentinan, reducing sugar and nano-silica are ground, water is added, and then enzymatic chicken liver powder and amino acid are added to react at 105-110 ℃ for 100-200 min.
10. The method for preparing the melanoidin composition according to claim 9, wherein in the step (3), the premix is cooled to 80-90 ℃, potassium sorbate is added, the mixture is cooled to 60-70 ℃ after being mixed for 10-15 min, and the algal polysaccharide mixture is added, mixed and dried to obtain the composition; the seaweed polysaccharide mixture is crushed before being added.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210176411.0A CN115590118B (en) | 2022-02-25 | 2022-02-25 | Melanoidin composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210176411.0A CN115590118B (en) | 2022-02-25 | 2022-02-25 | Melanoidin composition and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115590118A true CN115590118A (en) | 2023-01-13 |
| CN115590118B CN115590118B (en) | 2024-09-06 |
Family
ID=84841887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210176411.0A Active CN115590118B (en) | 2022-02-25 | 2022-02-25 | Melanoidin composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115590118B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116019215A (en) * | 2023-03-10 | 2023-04-28 | 江苏御娘食品有限公司 | Fragrant functional soybean protein seasoning, and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130287930A1 (en) * | 2010-12-16 | 2013-10-31 | Specialites Pet Food | Method for producing highly palatable dry cat food |
| CN105265761A (en) * | 2014-06-30 | 2016-01-27 | 上海翼邦生物技术有限公司 | Liquid state chicken liver flavored cat food flavoring agent preparing method |
| CN106720963A (en) * | 2016-12-23 | 2017-05-31 | 中国海洋大学 | A kind of krill pet nutrition flavouring agent and preparation method thereof |
| CN109043125A (en) * | 2018-07-17 | 2018-12-21 | 上海应用技术大学 | A kind of mushroom source dog grain phagostimulant and preparation method thereof |
| CN110463848A (en) * | 2019-09-29 | 2019-11-19 | 江苏翼邦生物技术有限公司 | One kind containing phosphatic cat flavouring agent and preparation method thereof |
-
2022
- 2022-02-25 CN CN202210176411.0A patent/CN115590118B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130287930A1 (en) * | 2010-12-16 | 2013-10-31 | Specialites Pet Food | Method for producing highly palatable dry cat food |
| CN105265761A (en) * | 2014-06-30 | 2016-01-27 | 上海翼邦生物技术有限公司 | Liquid state chicken liver flavored cat food flavoring agent preparing method |
| CN106720963A (en) * | 2016-12-23 | 2017-05-31 | 中国海洋大学 | A kind of krill pet nutrition flavouring agent and preparation method thereof |
| CN109043125A (en) * | 2018-07-17 | 2018-12-21 | 上海应用技术大学 | A kind of mushroom source dog grain phagostimulant and preparation method thereof |
| CN110463848A (en) * | 2019-09-29 | 2019-11-19 | 江苏翼邦生物技术有限公司 | One kind containing phosphatic cat flavouring agent and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 刘自力: "林产化工产品生产技术", vol. 01, 江西科学技术出版社, pages: 392 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116019215A (en) * | 2023-03-10 | 2023-04-28 | 江苏御娘食品有限公司 | Fragrant functional soybean protein seasoning, and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115590118B (en) | 2024-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1527670A (en) | Aimal growth regulating composition and its prepn and use | |
| CN104256097A (en) | Chitosan oligosaccharide-containing premixed feed for pets | |
| CN115590118A (en) | Melanoidin composition and preparation method thereof | |
| CN105724765A (en) | Feed additive of penaeus vannamei and preparation method and application thereof | |
| CN114027420A (en) | Selenium-rich organic litopenaeus vannamei and macrobrachium rosenbergii polyculture feed and preparation method thereof | |
| CN104222571A (en) | Production method of feed for chicken and poultries | |
| CN106333081B (en) | Feed additive containing amino acid | |
| CN109393207B (en) | Fish feed phagostimulant containing furfuryl isopropyl sulfide | |
| CN101044883A (en) | Feed additive for enhancing domestic animals or birds eating food and then accelerating their growth | |
| CN111011618A (en) | Preparation method of rumen-protected tryptophan particles | |
| CN106306480B (en) | Additive comprising sodium glutamate | |
| CN104206915B (en) | Promote production method and the application thereof of the additive of piglet growth | |
| CN112493364B (en) | Composition containing fish peptide powder and preparation method thereof | |
| CN106333082B (en) | Preparation method of amino acid compound feed additive | |
| CN113424903A (en) | Pig feed additive, preparation method and pig feed thereof | |
| CN112401088A (en) | Japanese eel adult eel feed and preparation method thereof | |
| CN111642636A (en) | Microbial fermentation cattle feed and preparation method thereof | |
| CN114224885B (en) | Compound amino acid soluble powder and preparation method thereof | |
| CN109744362B (en) | Mixed feed additive for tilapia | |
| JP3585295B2 (en) | Eggshell enhancer and feed | |
| CN111149927B (en) | Animal feed containing trace elements and preparation method thereof | |
| CN107183360A (en) | A kind of production and application process rich in chitosan oligosaccharide nutritive eggs feed | |
| CN106359896B (en) | Preparation process of additive containing sodium glutamate | |
| JP2000050813A (en) | Additive for domestic animal and domestic fowl containing degradation product of mannose-based polysaccharides | |
| CN108244351B (en) | Method for reducing powder content of granulated feed |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |